NEW YORK, March 07, 2018 (GLOBE NEWSWIRE) --

via NetworkWire – NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Lexaria Bioscience Corp. (CSE:LXX) (OTCQX:LXRP), a client of NNW that has developed and out-licenses its disruptive patented technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules.



To view the full publication, titled “Smokers Light Up Less, Alternative Nicotine Delivery Technologies Take Center Stage,” visit: http://nnw.fm/JZg2e

Lexaria Bioscience Corp. (CSE:LXX) (OTCQX:LXRP) is gaining prominence for its proprietary delivery technology capable of changing the way active pharmaceutical ingredients (“APIs”) such as cannabinoids and nicotine enter the body. The company’s DehydraTECH™ technology enables delivery of lipophilic active agents within foods, beverages, capsules and other ingestible formats, thus improving the performance of beneficial ingestible products across four categories: taste, smell, speed of action, and bioabsorption and bioavailability. DehyraTECH has already been proven effective in cannabinoid delivery and is currently undergoing testing for nicotine delivery in lab animals.

Lexaria’s technology is custom-designed to work with the human gastro intestinal (GI) system to deliver APIs more effectively (DehydraTECH can deliver payload molecules to the bloodstream in as little as 10 to 15 minutes, as opposed to 60 to 90 minutes for current methods), but still respects the body’s inherent internal safety mechanisms.

Delivering minute proportions of nicotine through edible food formats like coffee or breath mints has never been successfully achieved in the past, because when detected by the GI system, nicotine is generally flushed from the intestines through cramping and GI distress.

About Lexaria Bioscience Corp.

Lexaria Bioscience Corp. has developed and out-licenses its disruptive delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and was granted its first patents in the USA and in Australia related to edible forms of cannabinoids. Lexaria’s technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. For more information, visit www.LexariaEnergy.com.

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets, (3) enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge. For more information, please visit https://www.NetworkNewsWire.com .

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer .

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company's SEC filings. These risks and uncertainties could cause the company's actual results to differ materially from those indicated in the forward-looking statements.

Corporate Communications Contact: